Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema
Status:
Unknown status
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate if a combination therapy with micropulse
diode laser treatment shows non inferiority on visual acuity within 12 months in comparison
to standard therapy (intravitreal injection of ranibizumab only).